合計 50 件の最近のインサイダー取引記録が記録されています Oncternal Therapeutics, Inc. (ONCT), 内訳は 34 件の買い および 16 件の売り. インサイダー買い総額は $1.01M インサイダー売り総額は $1.35M.
最近活動のある主要インサイダーには Hale David F, Kisner Daniel L, Larue William R. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ONCT
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-06-20 |
Hale David F |
Director |
RSU 付与（制限付株式） |
3,300 |
$8.10 |
$26.73K |
3,300 |
| 2024-06-20 |
Kisner Daniel L |
Director |
RSU 付与（制限付株式） |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Larue William R |
Director |
RSU 付与（制限付株式） |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Carter Michael G |
Director |
RSU 付与（制限付株式） |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Mazanet Rosemary |
Director |
RSU 付与（制限付株式） |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Theuer Charles |
Director |
RSU 付与（制限付株式） |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Wills Robert James |
Director |
RSU 付与（制限付株式） |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Desimone Jill |
Director |
RSU 付与（制限付株式） |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-04-08 |
Wills Robert James |
Director |
情報に基づく買い |
3,086 |
$8.96 |
$27.65K |
10,000 |
| 2024-03-28 |
Wills Robert James |
Director |
情報に基づく買い |
6,914 |
$8.48 |
$58.6K |
6,914 |
| 2024-02-23 |
Hale David F |
Director |
情報に基づく買い |
714 |
$9.04 |
$6.45K |
714 |
| 2024-02-23 |
Wills Robert James |
Director |
情報に基づく売り |
980 |
$9.04 |
$8.86K |
- |
| 2024-02-14 |
Breitmeyer James B |
Chief Executive Officer |
RSU 付与（制限付株式） |
6,200 |
$9.18 |
$56.92K |
6,200 |
| 2024-02-14 |
Vincent Richard G |
Chief Financial Officer |
RSU 付与（制限付株式） |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Leavitt Chase C. |
General Counsel/secretary |
RSU 付与（制限付株式） |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Yazji Salim |
Chief Medical Officer |
RSU 付与（制限付株式） |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Krishnan Rajesh |
CTO/cso |
RSU 付与（制限付株式） |
17,700 |
$9.18 |
$162.49K |
17,700 |
| 2024-01-03 |
Breitmeyer James B |
Chief Executive Officer |
RSU 源泉徴収 |
4,485 |
$0.50 |
$2.23K |
15,426 |
| 2024-01-03 |
Vincent Richard G |
Chief Financial Officer |
RSU 源泉徴収 |
8,868 |
$0.50 |
$4.4K |
140,922 |
| 2024-01-03 |
Leavitt Chase C. |
General Counsel/secretary |
RSU 源泉徴収 |
11,838 |
$0.50 |
$5.87K |
84,758 |
| 2024-01-03 |
Yazji Salim |
Chief Medical Officer |
RSU 源泉徴収 |
19,742 |
$0.50 |
$9.79K |
128,635 |
| 2024-01-03 |
Krishnan Rajesh |
Chief Technical Officer |
RSU 源泉徴収 |
11,838 |
$0.50 |
$5.87K |
44,019 |
| 2023-10-02 |
Breitmeyer James B |
Chief Executive Officer |
株式返還 |
100,000 |
$5.76 |
$576K |
- |
| 2023-10-02 |
Vincent Richard G |
Chief Financial Officer |
株式返還 |
210,000 |
$0.96 |
$201.6K |
- |
| 2023-10-02 |
Leavitt Chase C. |
General Counsel/secretary |
株式返還 |
55,519 |
$1.94 |
$107.71K |
- |
| 2023-10-02 |
Yazji Salim |
Chief Medical Officer |
株式返還 |
210,000 |
$0.96 |
$201.6K |
- |
| 2023-10-02 |
Krishnan Rajesh |
Chief Technical Officer |
株式返還 |
220,000 |
$0.96 |
$211.2K |
- |
| 2023-07-03 |
Breitmeyer James B |
Chief Executive Officer |
RSU 源泉徴収 |
4,007 |
$0.36 |
$1.44K |
19,911 |
| 2023-07-03 |
Vincent Richard G |
Chief Financial Officer |
RSU 源泉徴収 |
7,069 |
$0.36 |
$2.54K |
149,790 |
| 2023-07-03 |
Leavitt Chase C. |
General Counsel/secretary |
RSU 源泉徴収 |
10,305 |
$0.36 |
$3.71K |
96,596 |
| 2023-07-03 |
Yazji Salim |
Chief Medical Officer |
RSU 源泉徴収 |
16,299 |
$0.36 |
$5.87K |
148,377 |
| 2023-07-03 |
Krishnan Rajesh |
Chief Technology Officer |
RSU 源泉徴収 |
10,897 |
$0.36 |
$3.92K |
55,857 |
| 2023-06-28 |
Hale David F |
Director |
RSU 付与（制限付株式） |
37,500 |
$0.36 |
$13.32K |
37,500 |
| 2023-06-28 |
Kisner Daniel L |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Larue William R |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Carter Michael G |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Mazanet Rosemary |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Theuer Charles |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Wills Robert James |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Nakanishi Xin |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Desimone Jill |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-14 |
Kaufmann Gunnar F. |
Chief Scientific Officer |
情報に基づく買い |
3,000 |
$0.36 |
$1.08K |
94,726 |
| 2023-06-12 |
Kaufmann Gunnar F. |
Chief Scientific Officer |
情報に基づく買い |
25,000 |
$0.35 |
$8.75K |
91,726 |
| 2023-04-14 |
Yazji Salim |
Chief Medical Officer |
情報に基づく買い |
5,000 |
$0.30 |
$1.5K |
164,676 |
| 2023-04-14 |
Breitmeyer James B |
Chief Executive Officer |
情報に基づく買い |
47,750 |
$0.30 |
$14.28K |
194,294 |
| 2023-04-13 |
Vincent Richard G |
Chief Financial Officer |
情報に基づく買い |
30,000 |
$0.30 |
$8.96K |
156,859 |
| 2023-04-13 |
Leavitt Chase C. |
General Counsel/secretary |
情報に基づく買い |
10,000 |
$0.29 |
$2.9K |
106,901 |
| 2023-04-13 |
Yazji Salim |
Chief Medical Officer |
情報に基づく買い |
10,000 |
$0.29 |
$2.85K |
159,676 |
| 2023-04-13 |
Breitmeyer James B |
Chief Executive Officer |
情報に基づく買い |
100,000 |
$0.29 |
$29K |
146,544 |
| 2023-04-12 |
Leavitt Chase C. |
General Counsel/secretary |
情報に基づく買い |
15,000 |
$0.29 |
$4.35K |
96,901 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
